Central Administration of Hydrogen Sulfide Donor NaHS Reduces Iba1-Positive Cells in the PVN and Attenuates Rodent Angiotensin II Hypertension

• Published in: Frontiers in neuroscience 2021-09, Vol.15, p.690919-690919
• Main Authors: Donertas Ayaz, Basak, Oliveira, Aline C, Malphurs, Wendi L, Redler, Ty, de Araujo, Alan Moreira, Sharma, Ravindra K, Sirmagul, Basar, Zubcevic, Jasenka
• Format: Article
• Language: English
• Subjects: hydrogen sulfide; hypertension; microbiota; microglia; neuroinflammation; Neuroscience; paraventricular nucleus
• ISSN: 1662-4548; 1662-453X; 1662-453X
• DOI: 10.3389/fnins.2021.690919

Hydrogen sulfide (H S) is a gaseous signaling molecule with neuromodulatory, anti-inflammatory, and anti-hypertensive effects. Here, we investigate whether chronic intracerebroventricular (ICV) infusion of sodium hydrosulfide (NaHS), an H S donor, can alleviate angiotensin II (Ang II)-induced hypertension (HTN), improve autonomic function, and impact microglia in the paraventricular nucleus (PVN) of the hypothalamus, a brain region associated with autonomic control of blood pressure (BP) and neuroinflammation in HTN. Chronic delivery of Ang II (200 ng/kg/min, subcutaneous) for 4 weeks produced a typical increase in BP and sympathetic drive and elevated the number of ionized calcium binding adaptor molecule 1-positive (Iba1 ) cells in the PVN of male, Sprague-Dawley rats. ICV co-infusion of NaHS (at 30 and/or 60 nmol/h) significantly attenuated these effects of Ang II. Ang II also increased the abundance of cecal and , among others, which was prevented by ICV NaHS co-infusion at 30 and 60 nmol/h. We observed no differences in circulating H S between the groups. Our results suggest that central H S may alleviate rodent HTN independently from circulating H S via effects on autonomic nervous system and PVN microglia.